These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 7851075

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
    Borg H, Gottsäter A, Fernlund P, Sundkvist G.
    Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
    Rattarasarn C, Diosdado MA.
    Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
    [Abstract] [Full Text] [Related]

  • 4. Is type 2 diabetes a different disease in obese and nonobese patients?
    Prando R, Cheli V, Melga P, Giusti R, Ciuchi E, Odetti P.
    Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivity.
    Hosker JP, Kumar S, Gordon C, Bhatnagar D, France M, Boulton AJ.
    Diabet Med; 1993 Jul; 10(6):509-13. PubMed ID: 8365085
    [Abstract] [Full Text] [Related]

  • 9. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C, Thamprasit A, Leelawattana R, Soonthornpun S, Setasuban W.
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V.
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [Abstract] [Full Text] [Related]

  • 16. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA, Sauerwald A, Ritzel R, Holst JJ, Schmiegel W.
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.